Patients with breast cancer have high levels of G-CSF, which supports M2-like macrophages, and anti-G-CSF treatment significantly reduced the proportion of MHCIIlow blood monocytes and TAM, as well as lung metastasis [42]. Here, CSF3 is linked to breast carcinoma.